MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63

Por Gamble, Laura D., Kees, Ursula R., Tweddle, Deborah A., Lunec, John
Publicado em 2011

Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma

Por Gamble, Laura D., Hogarty, Michael D., Liu, Xueyuan, Ziegler, David S., Marshall, Glenn, Norris, Murray D., Haber, Michelle
Publicado em 2012

p53 is a Direct Transcriptional Target of MYCN in Neuroblastoma

Por Chen, Lindi, Iraci, Nunzio, Gherardi, Samuele, Gamble, Laura D., Wood, Katrina M., Perini, Giovanni, Lunec, John, Tweddle, Deborah A.
Publicado em 2010